Mendelspod Podcast
Theral Timpson
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine. www.mendelspod.com
Episodes
Mentioned books
Apr 15, 2015 • 27min
Participation in Genomics Research a 21st Century Public Good, Says Paul Billings of Omicia
Pharma companies have always had their chief medical officers (CMOs). Now, as the diagnostics industry grows, many kinds of life science companies are filling this important position as well. Sequencing tool makers, direct-to-consumer firms, bioinformatics companies—they’re all appointing CMOs. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Apr 10, 2015 • 6min
Gene and Tonic: Competition for 23andMe, Four Tips for Attending AACR 2015, and "Swab Stories"
An Old New DTC Co. on the MoveLet’s start with a bit of trivia. What company has resorted to selling genetic ancestry testing online direct to consumers? Hint: the company is located in the San Francisco Bay area, has banked more than 800,000 samples from customers all over the world, and is slowly transforming itself into major biomedical player.That’s right. You got it. It’s Ancestry.com. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Apr 7, 2015 • 24min
Improving the Backbone of Clinical Genomics : Valerie Schneider, NCBI
When President Bill Clinton stood with Francis Collins and Craig Venter in 2001 to announce the sequencing of the genome, the genome wasn’t really done. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Apr 3, 2015 • 5min
Gene and Tonic: The ACA Turns Five, Ten Reasons to Have Your Genome Sequenced, and Humbled by the Ancients
Actually there was no news this week. It turns out the whole industry took the week off to watch the stunning Ken Burns documentary on cancer. No, that’s not true. We did find some news. How about this? The Affordable Care Act turned five this past week. Happy Birthday, ObamaCare! So we thought we’d share some important numbers about the ACA:11.7 million: the number of Americans who have signed up for 2015 coverage.46%: the increase in enrollment from 2014 to 2015. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Mar 31, 2015 • 23min
Behind the Sequencing Bench with Dale Yuzuki
Will tech companies like Google and Apple be good at life science applications? We pursue this question today with Dale Yuzuki, the avid life science blogger, scientist, and now a marketing manager at Thermo Fisher. (See his recent blog, The Core Competency of Google Is Not Life Sciences.) This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Mar 27, 2015 • 6min
Gene and Tonic: The Tenth Commandment of Science, Icelandic Treasure, and TechBio Babies
We were off last week, so there’s plenty to talk about. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Mar 19, 2015 • 21min
It’s Pretty Bad: Andy Brooks of RUCDR on Sample Quality
The future of diagnostics is in the hands of those taking care of the biospecimen samples says, Andy Brooks our final guest in the series, Improving Biospecimen Standards. Andy is the Chief Operating Officer at Rutgers University Cell and DNA Repository, or RUCDR. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Mar 17, 2015 • 22min
Knowing More about What We Don’t Know: John McPherson on Cancer Genomics
More than with any other major disease, the understanding and treatment of cancer is being transformed by genomics. And these are early days.John McPherson has been involved in sequencing since the original Human Genome Project. He now directs the Genome Technologies Program at the Ontario Institute for Cancer Research. John chaired a panel on cancer genomics at the recent AGBT, or Advances in Genome Biology and Technology conference, and shares his thoughts on this year's meeting. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Mar 13, 2015 • 4min
Gene and Tonic: The iWatch and Research Kit, 23andMe Goes for the Big Time, No Spaceship
Friday March 13thIt’s Friday already and time for Gene and Tonic, our wrap of the week’s headlines.On Monday, Apple’s CEO, Tim Cook, announced that the iWatch is indeed a reality. The iWatch has all the wearable techies and mobile health folks doing somersaults. But it was what happened afterward that was so interesting. Did you hear about this? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
Mar 12, 2015 • 16min
In Partnership with IBM’s Watson, Pathway Genomics Reinvents Itself
Direct-to-consumer (DTC) genetic testing has had a bumpy ride.Back in 2010, Pathway Genomics and Walgreens made a deal to sell DTC genetic tests in thousands of Walgreens drugstores. Within 48 hours of the deal being announced, it collapsed. The FDA sent a letter to Pathway basically asking them what the hell they were doing. Walgreens quickly elected to put the kibosh on the partnership. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
